Shi ST, Herlihy KJ, Graham JP, Fuhrman SA, Doan C, Parge H, Hickey M, Gao J, Yu X, Chau F, Gonzalez . In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA. Antimicrob Agents Chemother . 2008. 52(2). 675-683. Find at Google Scholar.
Cooper C, Lawitz EJ, Ghali P, Rodriguez-Torres M, Anderson FH, Lee SS, Bedard J, Chauret N, Thibert . Evaluation of VCH-759 monotherapy in hepatitis C infection. . J. Hepatol. . 2009. 51. 39-46. Find at Google Scholar.
Le Pogam S, Kang H, Harris SF, Leveque V, Giannetti AM, Ali S, Jiang WR, Rajyaguru S, Tavares G, Osh. Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonn. J Virol. . 2006. 80(12) . 6146-6154. Find at Google Scholar.
Nicolas O, Boivin I, Bedard J.. Genotypic analysis of HCV NS5b variants selected from patients treated with VCH-759, and viral load . J. Hepatol. . 2008. 48(2). S317. Find at Google Scholar.
Bartels D, Jiang M, Zhang E, Tigges A, Sullivan J, Dorrian J, Spanks J, Ardzinski A, Nicolas O, Beda. Characterization of HCV variants in genotype 1 patients administered VX-222, a non-nucleoside polyme. 5th International Workshop of Hepatitis C Res. 2010. . . Find at Google Scholar.